Intelligent digital health companion for neurocognitive disorders and caregivers
Official title: Talk-to-Jo" Intelligent Digital Health Companion, Neurocognitive Disorders and Dyads: a Qualitative Study
Run by Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal · NCT06606353 · Data updated 2026-11-12
This study is testing a digital health tool called 'Talk-to-Jo' to see if it can help older adults with neurocognitive disorders and their caregivers in Quebec feel better and manage their challenges.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal Government |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | December 12, 2024 |
| Main results expected | February 2026 |
| Study ends | October 2026 |
| Registry record updated | February 12, 2025 |
| Trial ID | NCT06606353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 65 and older diagnosed with a mild to moderate neurocognitive disorder and living with a caregiver.
✕Probably not a fit
Patients who are unable to understand spoken and written French or those living in long-term care facilities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on the use of an intelligent digital health companion, 'Talk-to-Jo', to support individuals aged 65 and older living with neurocognitive disorders (NCDs) and their caregivers. It aims to address the challenges faced by this population, particularly in Quebec, where access to primary care is often inadequate. The study will evaluate how this digital tool can improve the quality of life for patients and their caregivers by providing timely support and resources. Participants will be recruited from an outpatient clinic and must meet specific eligibility criteria, including language proficiency in French.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for patients with neurocognitive disorders and their caregivers by providing accessible support and resources.
How similar studies have gone: While the use of digital health companions is a growing field, this specific approach targeting neurocognitive disorders and caregivers is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Person living with an neurocognitive disorder (NCD):
1. Inclusion criteria:
* Be 65 years old or older.
* Have an NCD, whether minor or major, in a mild to moderate stage, diagnosed within the past year.
* Be receiving care for an NCD at the outpatient clinic of the Montreal Geriatric University Institute.
* Have a caregiver.
* Live in a personal residence or in a non-medicalized senior residence.
* Be able to understand spoken and written French. The "Talk-to-Jo" avatar has only been developed in the French language and can only communicate and understand French.
2. Exclusion criteria:
* Inability to provide informed consent for participation in the study.
* Participating in a concurrent experimental clinical study, to avoid interference with our study.
* Living in a Long-Term Care Facility or in a medicalized section of an non-medicalized senior residence.
* Inability to understand spoken and written French.
* Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
2. Caregiver
1. Inclusion criteria:
* Be a caregiver for a person living with an NCD (regardless of the relationship: spouse, child, friend, neighbor, family member).
* Be able to understand spoken and written French.
2. Exclusion criteria:
* Have an NCD.
* Inability to understand spoken and written French.
* Participating in a concurrent experimental clinical study, to avoid interference with our study.
* Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
Where it's running
-
Criugm
Montreal, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Olivier Beauchet, MD
- Email: olivier.beauchet@umontreal.ca
- Phone: 5143403540
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
Digital activity platform to support caregivers in long-term care
We’re testing a digital engagement platform to help formal and informal caregivers better support older adults in long-term care facilities.
-
Well-being program for caregivers of patients with advanced heart or lung disease
This study tests an 8-week, home-based wellness program delivered virtually to caregivers of people with advanced cardiac or pulmonary disease to see if it’s feasible and acceptable.
-
Music for Pain and Dementia: Group Drumming for people with early dementia and their caregivers
This study tests whether group drumming can reduce pain and change brain activity in people with mild dementia or mild cognitive impairment and in their caregivers.
-
PancreasPlus app for monitoring recovery, symptoms, and education after pancreatic cancer treatment
This project will test whether the PancreasPlus app helps adults with pancreatic cancer and their caregivers monitor symptoms, get timely information, and communicate with their healthcare team.
-
Non-invasive brain stimulation plus computer-based memory training for mild cognitive impairment
This trial will test whether a short course of non-invasive brain stimulation combined with one of two computer-based brain-training programs helps people aged 60–85 with mild cognitive impairment improve memory, thinking, mood, and daily function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.